Feds investigating Cincinnati Facebook breach

Laura Pedulli | | Health Exec | Cybersecurity

The Department of Health & Human Services (HHS) has launched a federal investigation into HIPAA privacy violations at the University of Cincinnati Medical Center, according to news sources.

The investigation follows a lawsuit filed earlier this month against the school for sensitive information posted on Facebook by two employees. A woman diagnosed with a sexually transmitted infection sued after the employees leaked her medical records online in a Facebook group called “Team No Hoes.”

The woman is suing two University of Cincinnati Medical Center employees for more than $25,000 in damages for allegedly publishing a screenshot of her syphilis diagnosis and "slut-shaming" her to the Facebook group's roughly 2,300 members, according to Cincinnati news outlet WLWT5.

The federal investigation was launched because of the school’s failure to report the incident to the HHS Office of Civil Rights.

Laura Pedulli

Related Content

FBI seeking extradition of Israeli prisoner accused of $500M in ransomware attacks
Data breach at chain of clinics impacts 450K patients
Nebraska becomes first state to sue Change Healthcare over data breach
Christmas ransomware exposed over 300K patient records to dark web
Cryo-frozen tissue manufacturer suffers cyberattack
First surgical device of its kind granted key FDA exemption

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.